Company record · ABT · Pharmaceutical Preparations
Abbott Laboratories
The principal financial officer who signed Abbott Laboratories's latest annual report is Philip P. Boudreau, verified February 20, 2026.
Roster record
| Officer | Philip P. Boudreau |
|---|---|
| Verified | February 20, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-03-13 also names Philip P. Boudreau alongside a Chief Financial Officer title. An 8-K with Item 5.02 was filed on 2026-04-27, after this 10-K; any CFO change it reports is tracked on the moves record. |
- sec.gov · signature block · “/s/ PHILIP P. BOUDREAU Robert B. Ford Philip P. Boudreau Chairman of the Board and Chief Executive Officer, and Director of Abbott Laboratories (principal executive officer) Executive Vice President, Finance and Chief Financial Officer (principal financial officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.